nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent—FABP7—breast cancer	0.538	0.808	CbGaD
Icosapent—PTGS1—breast cancer	0.0815	0.122	CbGaD
Icosapent—PTGS2—breast cancer	0.0466	0.0699	CbGaD
Icosapent—FABP7—mammary gland—breast cancer	0.00338	0.0445	CbGeAlD
Icosapent—SLC8A1—embryo—breast cancer	0.00314	0.0413	CbGeAlD
Icosapent—Dihomo-gamma-linolenic acid—FABP7—breast cancer	0.00288	0.499	CrCbGaD
Icosapent—PPARD—mammary gland—breast cancer	0.00267	0.0352	CbGeAlD
Icosapent—FADS1—nipple—breast cancer	0.00254	0.0334	CbGeAlD
Icosapent—FABP7—embryo—breast cancer	0.00231	0.0304	CbGeAlD
Icosapent—ACSL4—nipple—breast cancer	0.0023	0.0304	CbGeAlD
Icosapent—ACSL3—female reproductive system—breast cancer	0.00229	0.0302	CbGeAlD
Icosapent—Alpha-Linolenic Acid—FABP7—breast cancer	0.0022	0.382	CrCbGaD
Icosapent—PPARG—Topotecan—Irinotecan—breast cancer	0.00219	1	CbGdCrCtD
Icosapent—ACSL3—female gonad—breast cancer	0.00209	0.0275	CbGeAlD
Icosapent—ACSL3—endocrine gland—breast cancer	0.00194	0.0256	CbGeAlD
Icosapent—SLC8A1—female reproductive system—breast cancer	0.0019	0.0251	CbGeAlD
Icosapent—TRPV1—epithelium—breast cancer	0.00171	0.0225	CbGeAlD
Icosapent—SLC8A1—endocrine gland—breast cancer	0.00161	0.0212	CbGeAlD
Icosapent—FADS1—endometrium—breast cancer	0.00153	0.0202	CbGeAlD
Icosapent—FADS1—uterus—breast cancer	0.00141	0.0186	CbGeAlD
Icosapent—FABP7—female reproductive system—breast cancer	0.0014	0.0184	CbGeAlD
Icosapent—ACSL4—endometrium—breast cancer	0.00139	0.0183	CbGeAlD
Icosapent—FADS1—pituitary gland—breast cancer	0.00139	0.0183	CbGeAlD
Icosapent—FADS1—adipose tissue—breast cancer	0.00138	0.0182	CbGeAlD
Icosapent—ACSL4—uterus—breast cancer	0.00128	0.0169	CbGeAlD
Icosapent—TRPV1—female reproductive system—breast cancer	0.00127	0.0167	CbGeAlD
Icosapent—ACSL4—pituitary gland—breast cancer	0.00126	0.0166	CbGeAlD
Icosapent—ACSL4—adipose tissue—breast cancer	0.00125	0.0165	CbGeAlD
Icosapent—PPARG—mammary gland—breast cancer	0.00125	0.0165	CbGeAlD
Icosapent—FADS1—adrenal gland—breast cancer	0.00124	0.0163	CbGeAlD
Icosapent—PPARD—adipose tissue—breast cancer	0.0012	0.0159	CbGeAlD
Icosapent—FADS1—bone marrow—breast cancer	0.0012	0.0158	CbGeAlD
Icosapent—FABP7—endocrine gland—breast cancer	0.00118	0.0156	CbGeAlD
Icosapent—FADS1—female gonad—breast cancer	0.00115	0.0152	CbGeAlD
Icosapent—ACSL4—female reproductive system—breast cancer	0.00115	0.0152	CbGeAlD
Icosapent—ACSL4—adrenal gland—breast cancer	0.00112	0.0148	CbGeAlD
Icosapent—PPARD—female reproductive system—breast cancer	0.00111	0.0146	CbGeAlD
Icosapent—ACSL4—bone marrow—breast cancer	0.00109	0.0143	CbGeAlD
Icosapent—PPARD—adrenal gland—breast cancer	0.00108	0.0142	CbGeAlD
Icosapent—TRPV1—endocrine gland—breast cancer	0.00107	0.0141	CbGeAlD
Icosapent—ACSL4—female gonad—breast cancer	0.00105	0.0138	CbGeAlD
Icosapent—PPARG—nipple—breast cancer	0.00104	0.0137	CbGeAlD
Icosapent—PPARD—female gonad—breast cancer	0.00101	0.0133	CbGeAlD
Icosapent—ACSL4—endocrine gland—breast cancer	0.000974	0.0128	CbGeAlD
Icosapent—PPARD—endocrine gland—breast cancer	0.000936	0.0123	CbGeAlD
Icosapent—PPARG—embryo—breast cancer	0.000855	0.0113	CbGeAlD
Icosapent—FADS1—lymph node—breast cancer	0.000742	0.00978	CbGeAlD
Icosapent—PPARG—epithelium—breast cancer	0.000697	0.00919	CbGeAlD
Icosapent—ACSL4—lymph node—breast cancer	0.000674	0.00888	CbGeAlD
Icosapent—PPARG—skin of body—breast cancer	0.000663	0.00875	CbGeAlD
Icosapent—PPARD—lymph node—breast cancer	0.000647	0.00853	CbGeAlD
Icosapent—Oropharyngeal pain—Paclitaxel—breast cancer	0.000637	0.00735	CcSEcCtD
Icosapent—Constipation—Lapatinib—breast cancer	0.000633	0.0073	CcSEcCtD
Icosapent—Dysgeusia—Anastrozole—breast cancer	0.00063	0.00727	CcSEcCtD
Icosapent—Dysgeusia—Letrozole—breast cancer	0.00063	0.00727	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Fulvestrant—breast cancer	0.00062	0.00715	CcSEcCtD
Icosapent—Arthralgia—Exemestane—breast cancer	0.000616	0.00711	CcSEcCtD
Icosapent—Malnutrition—Idarubicin—breast cancer	0.000611	0.00705	CcSEcCtD
Icosapent—Dyspepsia—Fulvestrant—breast cancer	0.000599	0.00691	CcSEcCtD
Icosapent—Gastrointestinal disorder—Fulvestrant—breast cancer	0.000587	0.00678	CcSEcCtD
Icosapent—Constipation—Fulvestrant—breast cancer	0.000582	0.00671	CcSEcCtD
Icosapent—Arthralgia—Ixabepilone—breast cancer	0.000582	0.00671	CcSEcCtD
Icosapent—Gastrointestinal disorder—Toremifene—breast cancer	0.00058	0.00669	CcSEcCtD
Icosapent—PPARG—uterus—breast cancer	0.000576	0.0076	CbGeAlD
Icosapent—Constipation—Toremifene—breast cancer	0.000574	0.00663	CcSEcCtD
Icosapent—PPARG—adipose tissue—breast cancer	0.000564	0.00743	CbGeAlD
Icosapent—Aspartate aminotransferase increased—Vinorelbine—breast cancer	0.000563	0.0065	CcSEcCtD
Icosapent—PTGS1—nipple—breast cancer	0.000554	0.0073	CbGeAlD
Icosapent—Arthralgia—Letrozole—breast cancer	0.000548	0.00632	CcSEcCtD
Icosapent—Arthralgia—Anastrozole—breast cancer	0.000548	0.00632	CcSEcCtD
Icosapent—Oropharyngeal pain—Docetaxel—breast cancer	0.00054	0.00623	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Exemestane—breast cancer	0.000538	0.00621	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Thiotepa—breast cancer	0.000538	0.00621	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Thiotepa—breast cancer	0.000527	0.00608	CcSEcCtD
Icosapent—Anaphylactic shock—Anastrozole—breast cancer	0.000525	0.00606	CcSEcCtD
Icosapent—Anaphylactic shock—Letrozole—breast cancer	0.000525	0.00606	CcSEcCtD
Icosapent—Pruritus—Lapatinib—breast cancer	0.000523	0.00604	CcSEcCtD
Icosapent—Oropharyngeal pain—Capecitabine—breast cancer	0.000523	0.00603	CcSEcCtD
Icosapent—Dyspepsia—Exemestane—breast cancer	0.00052	0.006	CcSEcCtD
Icosapent—Arthralgia—Raloxifene—breast cancer	0.00052	0.006	CcSEcCtD
Icosapent—PPARG—female reproductive system—breast cancer	0.000518	0.00683	CbGeAlD
Icosapent—Gastrointestinal disorder—Exemestane—breast cancer	0.00051	0.00589	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Ixabepilone—breast cancer	0.000508	0.00586	CcSEcCtD
Icosapent—PPARG—adrenal gland—breast cancer	0.000506	0.00667	CbGeAlD
Icosapent—Constipation—Exemestane—breast cancer	0.000505	0.00583	CcSEcCtD
Icosapent—Anaphylactic shock—Idarubicin—breast cancer	0.000498	0.00575	CcSEcCtD
Icosapent—PPARG—bone marrow—breast cancer	0.000489	0.00645	CbGeAlD
Icosapent—Gastrointestinal disorder—Ixabepilone—breast cancer	0.000481	0.00556	CcSEcCtD
Icosapent—Pruritus—Fulvestrant—breast cancer	0.000481	0.00555	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Letrozole—breast cancer	0.000478	0.00552	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Anastrozole—breast cancer	0.000478	0.00552	CcSEcCtD
Icosapent—Constipation—Ixabepilone—breast cancer	0.000477	0.0055	CcSEcCtD
Icosapent—Pruritus—Toremifene—breast cancer	0.000475	0.00548	CcSEcCtD
Icosapent—PPARG—female gonad—breast cancer	0.000471	0.00622	CbGeAlD
Icosapent—Vomiting—Lapatinib—breast cancer	0.00047	0.00543	CcSEcCtD
Icosapent—Rash—Lapatinib—breast cancer	0.000466	0.00538	CcSEcCtD
Icosapent—Dermatitis—Lapatinib—breast cancer	0.000466	0.00538	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Irinotecan—breast cancer	0.000464	0.00536	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Mitoxantrone—breast cancer	0.000464	0.00536	CcSEcCtD
Icosapent—Dyspepsia—Letrozole—breast cancer	0.000462	0.00533	CcSEcCtD
Icosapent—Dyspepsia—Anastrozole—breast cancer	0.000462	0.00533	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Mitoxantrone—breast cancer	0.000455	0.00525	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Raloxifene—breast cancer	0.000454	0.00524	CcSEcCtD
Icosapent—Gastrointestinal disorder—Letrozole—breast cancer	0.000453	0.00523	CcSEcCtD
Icosapent—Gastrointestinal disorder—Anastrozole—breast cancer	0.000453	0.00523	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Gemcitabine—breast cancer	0.000452	0.00522	CcSEcCtD
Icosapent—Constipation—Anastrozole—breast cancer	0.000449	0.00518	CcSEcCtD
Icosapent—Constipation—Letrozole—breast cancer	0.000449	0.00518	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Gemcitabine—breast cancer	0.000443	0.00511	CcSEcCtD
Icosapent—Dyspepsia—Raloxifene—breast cancer	0.000439	0.00506	CcSEcCtD
Icosapent—PPARG—endocrine gland—breast cancer	0.000438	0.00578	CbGeAlD
Icosapent—PTGS2—embryo—breast cancer	0.000437	0.00576	CbGeAlD
Icosapent—Dihomo-gamma-linolenic acid—PTGS1—breast cancer	0.000436	0.0755	CrCbGaD
Icosapent—Vomiting—Fulvestrant—breast cancer	0.000433	0.00499	CcSEcCtD
Icosapent—Dysgeusia—Tamoxifen—breast cancer	0.000431	0.00498	CcSEcCtD
Icosapent—Gastrointestinal disorder—Raloxifene—breast cancer	0.00043	0.00496	CcSEcCtD
Icosapent—Rash—Fulvestrant—breast cancer	0.000429	0.00495	CcSEcCtD
Icosapent—Dermatitis—Fulvestrant—breast cancer	0.000429	0.00495	CcSEcCtD
Icosapent—Vomiting—Toremifene—breast cancer	0.000427	0.00493	CcSEcCtD
Icosapent—Rash—Toremifene—breast cancer	0.000423	0.00489	CcSEcCtD
Icosapent—Dermatitis—Toremifene—breast cancer	0.000423	0.00488	CcSEcCtD
Icosapent—Malnutrition—Goserelin—breast cancer	0.00042	0.00485	CcSEcCtD
Icosapent—Pruritus—Exemestane—breast cancer	0.000418	0.00482	CcSEcCtD
Icosapent—Pruritus—Ixabepilone—breast cancer	0.000394	0.00455	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Paclitaxel—breast cancer	0.000379	0.00437	CcSEcCtD
Icosapent—Malnutrition—Vinorelbine—breast cancer	0.000377	0.00435	CcSEcCtD
Icosapent—Vomiting—Exemestane—breast cancer	0.000376	0.00434	CcSEcCtD
Icosapent—Arthralgia—Tamoxifen—breast cancer	0.000375	0.00433	CcSEcCtD
Icosapent—PTGS1—epithelium—breast cancer	0.000373	0.00492	CbGeAlD
Icosapent—Rash—Exemestane—breast cancer	0.000373	0.0043	CcSEcCtD
Icosapent—Dermatitis—Exemestane—breast cancer	0.000372	0.0043	CcSEcCtD
Icosapent—Pruritus—Anastrozole—breast cancer	0.000371	0.00429	CcSEcCtD
Icosapent—Pruritus—Letrozole—breast cancer	0.000371	0.00429	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Paclitaxel—breast cancer	0.000371	0.00428	CcSEcCtD
Icosapent—Malnutrition—Thiotepa—breast cancer	0.00036	0.00415	CcSEcCtD
Icosapent—Arthralgia—Goserelin—breast cancer	0.000358	0.00413	CcSEcCtD
Icosapent—PTGS2—epithelium—breast cancer	0.000356	0.0047	CbGeAlD
Icosapent—Dyspepsia—Chlorambucil—breast cancer	0.000355	0.0041	CcSEcCtD
Icosapent—PTGS1—skin of body—breast cancer	0.000355	0.00468	CbGeAlD
Icosapent—Vomiting—Ixabepilone—breast cancer	0.000354	0.00409	CcSEcCtD
Icosapent—Anaphylactic shock—Melphalan—breast cancer	0.000352	0.00406	CcSEcCtD
Icosapent—Rash—Ixabepilone—breast cancer	0.000352	0.00406	CcSEcCtD
Icosapent—Dermatitis—Ixabepilone—breast cancer	0.000351	0.00405	CcSEcCtD
Icosapent—Gastrointestinal disorder—Chlorambucil—breast cancer	0.000348	0.00402	CcSEcCtD
Icosapent—Anaphylactic shock—Goserelin—breast cancer	0.000343	0.00396	CcSEcCtD
Icosapent—PTGS2—skin of body—breast cancer	0.000339	0.00447	CbGeAlD
Icosapent—PTGS1—endometrium—breast cancer	0.000334	0.00441	CbGeAlD
Icosapent—Vomiting—Anastrozole—breast cancer	0.000334	0.00385	CcSEcCtD
Icosapent—Vomiting—Letrozole—breast cancer	0.000334	0.00385	CcSEcCtD
Icosapent—Rash—Anastrozole—breast cancer	0.000331	0.00382	CcSEcCtD
Icosapent—Rash—Letrozole—breast cancer	0.000331	0.00382	CcSEcCtD
Icosapent—Dermatitis—Letrozole—breast cancer	0.000331	0.00382	CcSEcCtD
Icosapent—Dermatitis—Anastrozole—breast cancer	0.000331	0.00382	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Tamoxifen—breast cancer	0.000327	0.00378	CcSEcCtD
Icosapent—Eructation—Epirubicin—breast cancer	0.000325	0.00376	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Docetaxel—breast cancer	0.000321	0.00371	CcSEcCtD
Icosapent—Arthralgia—Vinorelbine—breast cancer	0.000321	0.0037	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Melphalan—breast cancer	0.00032	0.0037	CcSEcCtD
Icosapent—PTGS2—endometrium—breast cancer	0.00032	0.00421	CbGeAlD
Icosapent—Vomiting—Idarubicin—breast cancer	0.000317	0.00366	CcSEcCtD
Icosapent—Vomiting—Raloxifene—breast cancer	0.000317	0.00366	CcSEcCtD
Icosapent—Constipation—Vinblastine—breast cancer	0.000316	0.00365	CcSEcCtD
Icosapent—Dyspepsia—Tamoxifen—breast cancer	0.000316	0.00365	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Docetaxel—breast cancer	0.000314	0.00363	CcSEcCtD
Icosapent—Rash—Raloxifene—breast cancer	0.000314	0.00363	CcSEcCtD
Icosapent—Rash—Idarubicin—breast cancer	0.000314	0.00363	CcSEcCtD
Icosapent—Dermatitis—Raloxifene—breast cancer	0.000314	0.00362	CcSEcCtD
Icosapent—Dermatitis—Idarubicin—breast cancer	0.000314	0.00362	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Goserelin—breast cancer	0.000313	0.00361	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Capecitabine—breast cancer	0.000311	0.00359	CcSEcCtD
Icosapent—Gastrointestinal disorder—Tamoxifen—breast cancer	0.00031	0.00358	CcSEcCtD
Icosapent—Dyspepsia—Melphalan—breast cancer	0.00031	0.00357	CcSEcCtD
Icosapent—PTGS1—uterus—breast cancer	0.000308	0.00406	CbGeAlD
Icosapent—Anaphylactic shock—Vinorelbine—breast cancer	0.000307	0.00355	CcSEcCtD
Icosapent—Constipation—Tamoxifen—breast cancer	0.000307	0.00355	CcSEcCtD
Icosapent—Arthralgia—Thiotepa—breast cancer	0.000306	0.00353	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Capecitabine—breast cancer	0.000304	0.00351	CcSEcCtD
Icosapent—Dysgeusia—Mitoxantrone—breast cancer	0.000304	0.00351	CcSEcCtD
Icosapent—Gastrointestinal disorder—Melphalan—breast cancer	0.000304	0.00351	CcSEcCtD
Icosapent—PPARG—lymph node—breast cancer	0.000303	0.004	CbGeAlD
Icosapent—PTGS1—pituitary gland—breast cancer	0.000303	0.00399	CbGeAlD
Icosapent—Dyspepsia—Goserelin—breast cancer	0.000302	0.00349	CcSEcCtD
Icosapent—PTGS1—adipose tissue—breast cancer	0.000301	0.00397	CbGeAlD
Icosapent—Eructation—Doxorubicin—breast cancer	0.000301	0.00348	CcSEcCtD
Icosapent—PTGS2—uterus—breast cancer	0.000294	0.00388	CbGeAlD
Icosapent—Constipation—Goserelin—breast cancer	0.000293	0.00339	CcSEcCtD
Icosapent—PTGS2—pituitary gland—breast cancer	0.000289	0.00381	CbGeAlD
Icosapent—PTGS2—adipose tissue—breast cancer	0.000288	0.0038	CbGeAlD
Icosapent—Pruritus—Chlorambucil—breast cancer	0.000286	0.0033	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Vinorelbine—breast cancer	0.00028	0.00323	CcSEcCtD
Icosapent—PTGS1—female reproductive system—breast cancer	0.000277	0.00365	CbGeAlD
Icosapent—PTGS1—adrenal gland—breast cancer	0.00027	0.00356	CbGeAlD
Icosapent—Musculoskeletal discomfort—Thiotepa—breast cancer	0.000267	0.00309	CcSEcCtD
Icosapent—Gastrointestinal disorder—Vinorelbine—breast cancer	0.000265	0.00306	CcSEcCtD
Icosapent—PTGS2—female reproductive system—breast cancer	0.000265	0.00349	CbGeAlD
Icosapent—Arthralgia—Mitoxantrone—breast cancer	0.000264	0.00305	CcSEcCtD
Icosapent—Constipation—Vinorelbine—breast cancer	0.000263	0.00303	CcSEcCtD
Icosapent—Dyspepsia—Thiotepa—breast cancer	0.000258	0.00298	CcSEcCtD
Icosapent—PTGS2—adrenal gland—breast cancer	0.000258	0.00341	CbGeAlD
Icosapent—Arthralgia—Gemcitabine—breast cancer	0.000258	0.00297	CcSEcCtD
Icosapent—Vomiting—Chlorambucil—breast cancer	0.000257	0.00296	CcSEcCtD
Icosapent—Pruritus—Tamoxifen—breast cancer	0.000254	0.00293	CcSEcCtD
Icosapent—Anaphylactic shock—Mitoxantrone—breast cancer	0.000253	0.00293	CcSEcCtD
Icosapent—Anaphylactic shock—Irinotecan—breast cancer	0.000253	0.00293	CcSEcCtD
Icosapent—Gastrointestinal disorder—Thiotepa—breast cancer	0.000253	0.00292	CcSEcCtD
Icosapent—Malnutrition—Paclitaxel—breast cancer	0.000253	0.00292	CcSEcCtD
Icosapent—PTGS1—female gonad—breast cancer	0.000252	0.00332	CbGeAlD
Icosapent—Constipation—Thiotepa—breast cancer	0.000251	0.0029	CcSEcCtD
Icosapent—PTGS2—bone marrow—breast cancer	0.00025	0.0033	CbGeAlD
Icosapent—Dihomo-gamma-linolenic acid—PTGS2—breast cancer	0.000249	0.0432	CrCbGaD
Icosapent—Pruritus—Melphalan—breast cancer	0.000249	0.00287	CcSEcCtD
Icosapent—Dysgeusia—Paclitaxel—breast cancer	0.000248	0.00286	CcSEcCtD
Icosapent—Anaphylactic shock—Gemcitabine—breast cancer	0.000247	0.00285	CcSEcCtD
Icosapent—Pruritus—Goserelin—breast cancer	0.000243	0.0028	CcSEcCtD
Icosapent—Anaphylactic shock—Fluorouracil—breast cancer	0.000243	0.0028	CcSEcCtD
Icosapent—PTGS2—female gonad—breast cancer	0.000241	0.00318	CbGeAlD
Icosapent—Vomiting—Vinblastine—breast cancer	0.000235	0.00271	CcSEcCtD
Icosapent—PTGS1—endocrine gland—breast cancer	0.000234	0.00309	CbGeAlD
Icosapent—Musculoskeletal discomfort—Mitoxantrone—breast cancer	0.000231	0.00267	CcSEcCtD
Icosapent—Vomiting—Tamoxifen—breast cancer	0.000228	0.00264	CcSEcCtD
Icosapent—Rash—Tamoxifen—breast cancer	0.000227	0.00261	CcSEcCtD
Icosapent—Dermatitis—Tamoxifen—breast cancer	0.000226	0.00261	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Gemcitabine—breast cancer	0.000225	0.0026	CcSEcCtD
Icosapent—PTGS2—endocrine gland—breast cancer	0.000224	0.00295	CbGeAlD
Icosapent—Vomiting—Melphalan—breast cancer	0.000224	0.00258	CcSEcCtD
Icosapent—Dyspepsia—Irinotecan—breast cancer	0.000223	0.00258	CcSEcCtD
Icosapent—Dyspepsia—Mitoxantrone—breast cancer	0.000223	0.00258	CcSEcCtD
Icosapent—Rash—Melphalan—breast cancer	0.000222	0.00256	CcSEcCtD
Icosapent—Dermatitis—Melphalan—breast cancer	0.000222	0.00256	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Fluorouracil—breast cancer	0.000221	0.00255	CcSEcCtD
Icosapent—Gastrointestinal disorder—Irinotecan—breast cancer	0.000219	0.00253	CcSEcCtD
Icosapent—Vomiting—Goserelin—breast cancer	0.000218	0.00252	CcSEcCtD
Icosapent—Pruritus—Vinorelbine—breast cancer	0.000217	0.00251	CcSEcCtD
Icosapent—Constipation—Irinotecan—breast cancer	0.000217	0.0025	CcSEcCtD
Icosapent—Constipation—Mitoxantrone—breast cancer	0.000217	0.0025	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Epirubicin—breast cancer	0.000217	0.0025	CcSEcCtD
Icosapent—Rash—Goserelin—breast cancer	0.000216	0.0025	CcSEcCtD
Icosapent—Dermatitis—Goserelin—breast cancer	0.000216	0.00249	CcSEcCtD
Icosapent—Arthralgia—Paclitaxel—breast cancer	0.000216	0.00249	CcSEcCtD
Icosapent—Malnutrition—Docetaxel—breast cancer	0.000215	0.00248	CcSEcCtD
Icosapent—Dyspepsia—Fluorouracil—breast cancer	0.000214	0.00247	CcSEcCtD
Icosapent—Gastrointestinal disorder—Gemcitabine—breast cancer	0.000213	0.00246	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Epirubicin—breast cancer	0.000212	0.00245	CcSEcCtD
Icosapent—Constipation—Gemcitabine—breast cancer	0.000211	0.00244	CcSEcCtD
Icosapent—Dysgeusia—Docetaxel—breast cancer	0.00021	0.00243	CcSEcCtD
Icosapent—Gastrointestinal disorder—Fluorouracil—breast cancer	0.00021	0.00242	CcSEcCtD
Icosapent—Malnutrition—Capecitabine—breast cancer	0.000208	0.0024	CcSEcCtD
Icosapent—Pruritus—Thiotepa—breast cancer	0.000208	0.0024	CcSEcCtD
Icosapent—Anaphylactic shock—Paclitaxel—breast cancer	0.000207	0.00239	CcSEcCtD
Icosapent—Dysgeusia—Capecitabine—breast cancer	0.000204	0.00235	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Doxorubicin—breast cancer	0.0002	0.00231	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Doxorubicin—breast cancer	0.000196	0.00226	CcSEcCtD
Icosapent—Vomiting—Vinorelbine—breast cancer	0.000195	0.00226	CcSEcCtD
Icosapent—Rash—Vinorelbine—breast cancer	0.000194	0.00224	CcSEcCtD
Icosapent—Dermatitis—Vinorelbine—breast cancer	0.000194	0.00223	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Paclitaxel—breast cancer	0.000188	0.00217	CcSEcCtD
Icosapent—Vomiting—Thiotepa—breast cancer	0.000187	0.00215	CcSEcCtD
Icosapent—Rash—Thiotepa—breast cancer	0.000185	0.00214	CcSEcCtD
Icosapent—Dermatitis—Thiotepa—breast cancer	0.000185	0.00213	CcSEcCtD
Icosapent—Arthralgia—Docetaxel—breast cancer	0.000183	0.00211	CcSEcCtD
Icosapent—Dyspepsia—Paclitaxel—breast cancer	0.000182	0.0021	CcSEcCtD
Icosapent—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000178	0.00206	CcSEcCtD
Icosapent—Arthralgia—Capecitabine—breast cancer	0.000177	0.00204	CcSEcCtD
Icosapent—Constipation—Paclitaxel—breast cancer	0.000177	0.00204	CcSEcCtD
Icosapent—Anaphylactic shock—Docetaxel—breast cancer	0.000175	0.00202	CcSEcCtD
Icosapent—Pruritus—Gemcitabine—breast cancer	0.000175	0.00202	CcSEcCtD
Icosapent—Pruritus—Fluorouracil—breast cancer	0.000172	0.00198	CcSEcCtD
Icosapent—PTGS1—lymph node—breast cancer	0.000162	0.00214	CbGeAlD
Icosapent—Vomiting—Mitoxantrone—breast cancer	0.000161	0.00186	CcSEcCtD
Icosapent—Vomiting—Irinotecan—breast cancer	0.000161	0.00186	CcSEcCtD
Icosapent—Rash—Irinotecan—breast cancer	0.00016	0.00184	CcSEcCtD
Icosapent—Rash—Mitoxantrone—breast cancer	0.00016	0.00184	CcSEcCtD
Icosapent—Dermatitis—Irinotecan—breast cancer	0.00016	0.00184	CcSEcCtD
Icosapent—Dermatitis—Mitoxantrone—breast cancer	0.00016	0.00184	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Docetaxel—breast cancer	0.00016	0.00184	CcSEcCtD
Icosapent—Vomiting—Gemcitabine—breast cancer	0.000157	0.00181	CcSEcCtD
Icosapent—Rash—Gemcitabine—breast cancer	0.000156	0.0018	CcSEcCtD
Icosapent—Dermatitis—Gemcitabine—breast cancer	0.000156	0.0018	CcSEcCtD
Icosapent—PTGS2—lymph node—breast cancer	0.000155	0.00204	CbGeAlD
Icosapent—Malnutrition—Methotrexate—breast cancer	0.000155	0.00179	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000155	0.00178	CcSEcCtD
Icosapent—Vomiting—Fluorouracil—breast cancer	0.000154	0.00178	CcSEcCtD
Icosapent—Dyspepsia—Docetaxel—breast cancer	0.000154	0.00178	CcSEcCtD
Icosapent—Rash—Fluorouracil—breast cancer	0.000153	0.00177	CcSEcCtD
Icosapent—Dermatitis—Fluorouracil—breast cancer	0.000153	0.00176	CcSEcCtD
Icosapent—Dysgeusia—Methotrexate—breast cancer	0.000152	0.00175	CcSEcCtD
Icosapent—Gastrointestinal disorder—Docetaxel—breast cancer	0.000151	0.00175	CcSEcCtD
Icosapent—Constipation—Docetaxel—breast cancer	0.00015	0.00173	CcSEcCtD
Icosapent—Dyspepsia—Capecitabine—breast cancer	0.000149	0.00172	CcSEcCtD
Icosapent—Gastrointestinal disorder—Capecitabine—breast cancer	0.000146	0.00169	CcSEcCtD
Icosapent—Pruritus—Paclitaxel—breast cancer	0.000146	0.00169	CcSEcCtD
Icosapent—Constipation—Capecitabine—breast cancer	0.000145	0.00167	CcSEcCtD
Icosapent—Malnutrition—Epirubicin—breast cancer	0.000145	0.00167	CcSEcCtD
Icosapent—Dysgeusia—Epirubicin—breast cancer	0.000142	0.00164	CcSEcCtD
Icosapent—Malnutrition—Doxorubicin—breast cancer	0.000134	0.00155	CcSEcCtD
Icosapent—Arthralgia—Methotrexate—breast cancer	0.000132	0.00152	CcSEcCtD
Icosapent—Vomiting—Paclitaxel—breast cancer	0.000131	0.00152	CcSEcCtD
Icosapent—Dysgeusia—Doxorubicin—breast cancer	0.000131	0.00151	CcSEcCtD
Icosapent—Rash—Paclitaxel—breast cancer	0.00013	0.0015	CcSEcCtD
Icosapent—Dermatitis—Paclitaxel—breast cancer	0.00013	0.0015	CcSEcCtD
Icosapent—Anaphylactic shock—Methotrexate—breast cancer	0.000126	0.00146	CcSEcCtD
Icosapent—Pruritus—Docetaxel—breast cancer	0.000124	0.00143	CcSEcCtD
Icosapent—Arthralgia—Epirubicin—breast cancer	0.000123	0.00142	CcSEcCtD
Icosapent—Pruritus—Capecitabine—breast cancer	0.00012	0.00139	CcSEcCtD
Icosapent—Anaphylactic shock—Epirubicin—breast cancer	0.000118	0.00136	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Methotrexate—breast cancer	0.000115	0.00133	CcSEcCtD
Icosapent—Arthralgia—Doxorubicin—breast cancer	0.000114	0.00132	CcSEcCtD
Icosapent—Vomiting—Docetaxel—breast cancer	0.000111	0.00129	CcSEcCtD
Icosapent—Dyspepsia—Methotrexate—breast cancer	0.000111	0.00128	CcSEcCtD
Icosapent—Rash—Docetaxel—breast cancer	0.00011	0.00128	CcSEcCtD
Icosapent—Dermatitis—Docetaxel—breast cancer	0.00011	0.00127	CcSEcCtD
Icosapent—Anaphylactic shock—Doxorubicin—breast cancer	0.000109	0.00126	CcSEcCtD
Icosapent—Gastrointestinal disorder—Methotrexate—breast cancer	0.000109	0.00126	CcSEcCtD
Icosapent—Vomiting—Capecitabine—breast cancer	0.000108	0.00124	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Epirubicin—breast cancer	0.000108	0.00124	CcSEcCtD
Icosapent—Rash—Capecitabine—breast cancer	0.000107	0.00123	CcSEcCtD
Icosapent—Dermatitis—Capecitabine—breast cancer	0.000107	0.00123	CcSEcCtD
Icosapent—Dyspepsia—Epirubicin—breast cancer	0.000104	0.0012	CcSEcCtD
Icosapent—Gastrointestinal disorder—Epirubicin—breast cancer	0.000102	0.00118	CcSEcCtD
Icosapent—Constipation—Epirubicin—breast cancer	0.000101	0.00117	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Doxorubicin—breast cancer	9.96e-05	0.00115	CcSEcCtD
Icosapent—Dyspepsia—Doxorubicin—breast cancer	9.63e-05	0.00111	CcSEcCtD
Icosapent—Gastrointestinal disorder—Doxorubicin—breast cancer	9.44e-05	0.00109	CcSEcCtD
Icosapent—Constipation—Doxorubicin—breast cancer	9.35e-05	0.00108	CcSEcCtD
Icosapent—Pruritus—Methotrexate—breast cancer	8.93e-05	0.00103	CcSEcCtD
Icosapent—Pruritus—Epirubicin—breast cancer	8.36e-05	0.000965	CcSEcCtD
Icosapent—Vomiting—Methotrexate—breast cancer	8.03e-05	0.000927	CcSEcCtD
Icosapent—Rash—Methotrexate—breast cancer	7.96e-05	0.000919	CcSEcCtD
Icosapent—Dermatitis—Methotrexate—breast cancer	7.96e-05	0.000918	CcSEcCtD
Icosapent—Pruritus—Doxorubicin—breast cancer	7.74e-05	0.000893	CcSEcCtD
Icosapent—Vomiting—Epirubicin—breast cancer	7.51e-05	0.000867	CcSEcCtD
Icosapent—Rash—Epirubicin—breast cancer	7.45e-05	0.00086	CcSEcCtD
Icosapent—Dermatitis—Epirubicin—breast cancer	7.44e-05	0.000859	CcSEcCtD
Icosapent—Vomiting—Doxorubicin—breast cancer	6.95e-05	0.000802	CcSEcCtD
Icosapent—Rash—Doxorubicin—breast cancer	6.89e-05	0.000796	CcSEcCtD
Icosapent—Dermatitis—Doxorubicin—breast cancer	6.89e-05	0.000795	CcSEcCtD
Icosapent—PPARG—Developmental Biology—SRC—breast cancer	6.12e-06	3.74e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—MAPK3—breast cancer	6.11e-06	3.73e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—JAG2—breast cancer	6.1e-06	3.73e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—IDH1—breast cancer	6.08e-06	3.71e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GSTA1—breast cancer	6.08e-06	3.71e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	6.07e-06	3.71e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—HPGDS—breast cancer	6.05e-06	3.7e-05	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—PIK3CA—breast cancer	6.03e-06	3.69e-05	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—PIK3CA—breast cancer	6.03e-06	3.69e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	6.02e-06	3.68e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—NOS3—breast cancer	6.02e-06	3.68e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—HBA1—breast cancer	6.01e-06	3.68e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—WNT1—breast cancer	6.01e-06	3.68e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—NAT2—breast cancer	6.01e-06	3.67e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—SLC2A2—breast cancer	5.97e-06	3.65e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—VEGFA—breast cancer	5.96e-06	3.64e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—MYC—breast cancer	5.94e-06	3.63e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—TGFB1—breast cancer	5.93e-06	3.62e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—STAT3—breast cancer	5.9e-06	3.61e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—PTEN—breast cancer	5.89e-06	3.6e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—GSTT1—breast cancer	5.87e-06	3.59e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ACHE—breast cancer	5.87e-06	3.59e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—MTR—breast cancer	5.85e-06	3.58e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—COMT—breast cancer	5.83e-06	3.57e-05	CbGpPWpGaD
Icosapent—PPARG—Generic Transcription Pathway—MYC—breast cancer	5.82e-06	3.56e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—EGFR—breast cancer	5.81e-06	3.55e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—GSTP1—breast cancer	5.81e-06	3.55e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—HMOX1—breast cancer	5.73e-06	3.5e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—ITPR1—breast cancer	5.71e-06	3.49e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—MAPK3—breast cancer	5.64e-06	3.45e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PIK3CB—breast cancer	5.56e-06	3.4e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CYP17A1—breast cancer	5.55e-06	3.4e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	5.53e-06	3.38e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PTGS2—breast cancer	5.51e-06	3.37e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ENO1—breast cancer	5.5e-06	3.36e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—ABCB1—breast cancer	5.5e-06	3.36e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—KRAS—breast cancer	5.49e-06	3.36e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	5.48e-06	3.35e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—TGFB1—breast cancer	5.47e-06	3.34e-05	CbGpPWpGaD
Icosapent—FADS1—Metabolism—AKT1—breast cancer	5.45e-06	3.33e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—HSPA1B—breast cancer	5.44e-06	3.32e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	5.43e-06	3.32e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—ALB—breast cancer	5.41e-06	3.31e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—TYMS—breast cancer	5.4e-06	3.3e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CYP2D6—breast cancer	5.39e-06	3.3e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—ESR1—breast cancer	5.39e-06	3.3e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—EGFR—breast cancer	5.36e-06	3.28e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	5.35e-06	3.27e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PLA2G4A—breast cancer	5.34e-06	3.26e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—NCOR1—breast cancer	5.34e-06	3.26e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—GSTM1—breast cancer	5.34e-06	3.26e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—NCOA2—breast cancer	5.29e-06	3.24e-05	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—MAPK3—breast cancer	5.28e-06	3.23e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—DPYD—breast cancer	5.27e-06	3.22e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—MED12—breast cancer	5.27e-06	3.22e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—ENO1—breast cancer	5.21e-06	3.19e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—NOTCH1—breast cancer	5.21e-06	3.19e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ALDOA—breast cancer	5.19e-06	3.17e-05	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—MYC—breast cancer	5.14e-06	3.14e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—FASN—breast cancer	5.13e-06	3.14e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—BCHE—breast cancer	5.11e-06	3.13e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—GPX1—breast cancer	5.11e-06	3.12e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—TNF—breast cancer	5.11e-06	3.12e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—KRAS—breast cancer	5.06e-06	3.1e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CYP1A1—breast cancer	5.06e-06	3.09e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—SLC5A5—breast cancer	5.05e-06	3.09e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—PIK3CA—breast cancer	5.04e-06	3.08e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—NCOA3—breast cancer	5.03e-06	3.08e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—ERCC2—breast cancer	5.02e-06	3.07e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—SLC2A2—breast cancer	5e-06	3.06e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	4.95e-06	3.02e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—FGF3—breast cancer	4.93e-06	3.01e-05	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—AKT1—breast cancer	4.93e-06	3.01e-05	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—AKT1—breast cancer	4.93e-06	3.01e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CPT1A—breast cancer	4.9e-06	2.99e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ABCG2—breast cancer	4.9e-06	2.99e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—MTR—breast cancer	4.9e-06	2.99e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—TP53—breast cancer	4.88e-06	2.98e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—SLC2A1—breast cancer	4.88e-06	2.98e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—NQO1—breast cancer	4.88e-06	2.98e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—FASN—breast cancer	4.87e-06	2.98e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—JAG1—breast cancer	4.87e-06	2.98e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—PARP1—breast cancer	4.85e-06	2.96e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PTEN—breast cancer	4.8e-06	2.94e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—HPGDS—breast cancer	4.8e-06	2.94e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CALCA—breast cancer	4.79e-06	2.93e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	4.78e-06	2.92e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—HBA1—breast cancer	4.77e-06	2.92e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CYP3A4—breast cancer	4.76e-06	2.91e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.73e-06	2.89e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—RPS6—breast cancer	4.73e-06	2.89e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—MTHFR—breast cancer	4.72e-06	2.88e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—FGF4—breast cancer	4.69e-06	2.87e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CYP1B1—breast cancer	4.68e-06	2.86e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CXCR4—breast cancer	4.68e-06	2.86e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—HRAS—breast cancer	4.67e-06	2.85e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ACHE—breast cancer	4.66e-06	2.85e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GSTT1—breast cancer	4.66e-06	2.85e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—SLC2A1—breast cancer	4.62e-06	2.83e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—HSP90AA1—breast cancer	4.59e-06	2.8e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	4.52e-06	2.76e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—TCF7L2—breast cancer	4.51e-06	2.76e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—IL6—breast cancer	4.47e-06	2.73e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—NCOA1—breast cancer	4.46e-06	2.73e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—SERPINE1—breast cancer	4.43e-06	2.71e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CYP17A1—breast cancer	4.41e-06	2.7e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CYP19A1—breast cancer	4.4e-06	2.69e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—STK11—breast cancer	4.4e-06	2.69e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PTGS1—breast cancer	4.37e-06	2.67e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ENO1—breast cancer	4.37e-06	2.67e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CAV1—breast cancer	4.35e-06	2.66e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	4.35e-06	2.66e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—HSP90AA1—breast cancer	4.35e-06	2.66e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—HRAS—breast cancer	4.31e-06	2.63e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—ALB—breast cancer	4.29e-06	2.63e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CYP2D6—breast cancer	4.28e-06	2.62e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—PRL—breast cancer	4.23e-06	2.59e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—NCOA2—breast cancer	4.2e-06	2.57e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—ADAM10—breast cancer	4.17e-06	2.55e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.16e-06	2.54e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.13e-06	2.52e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—IL6—breast cancer	4.12e-06	2.52e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—AKT1—breast cancer	4.12e-06	2.52e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—COMT—breast cancer	4.09e-06	2.5e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—FASN—breast cancer	4.08e-06	2.49e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—GSTP1—breast cancer	4.07e-06	2.49e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—BCHE—breast cancer	4.06e-06	2.48e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—FGF10—breast cancer	4.05e-06	2.48e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—HMOX1—breast cancer	4.01e-06	2.45e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—SLC5A5—breast cancer	4.01e-06	2.45e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ITPR1—breast cancer	4e-06	2.45e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PIK3CG—breast cancer	3.96e-06	2.42e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—PDGFA—breast cancer	3.91e-06	2.39e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—SLC2A1—breast cancer	3.87e-06	2.37e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—NQO1—breast cancer	3.87e-06	2.37e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—TGFBR2—breast cancer	3.86e-06	2.36e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ABCB1—breast cancer	3.85e-06	2.35e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—AKT1—breast cancer	3.8e-06	2.32e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—ITPR1—breast cancer	3.79e-06	2.32e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.79e-06	2.32e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—TYMS—breast cancer	3.78e-06	2.31e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CYP3A4—breast cancer	3.78e-06	2.31e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—ERBB4—breast cancer	3.77e-06	2.3e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—STAT5A—breast cancer	3.77e-06	2.3e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PLA2G4A—breast cancer	3.74e-06	2.29e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—GSTM1—breast cancer	3.74e-06	2.29e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—NCOR1—breast cancer	3.74e-06	2.29e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CYP1B1—breast cancer	3.71e-06	2.27e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—SMAD4—breast cancer	3.65e-06	2.23e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—HSP90AA1—breast cancer	3.64e-06	2.23e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—GPX1—breast cancer	3.58e-06	2.19e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—HES1—breast cancer	3.56e-06	2.18e-05	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—AKT1—breast cancer	3.56e-06	2.18e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CYP1A1—breast cancer	3.54e-06	2.17e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—NCOR1—breast cancer	3.54e-06	2.17e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—NCOA1—breast cancer	3.54e-06	2.16e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ERCC2—breast cancer	3.51e-06	2.15e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—FGF1—breast cancer	3.5e-06	2.14e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—STK11—breast cancer	3.49e-06	2.13e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CYP19A1—breast cancer	3.49e-06	2.13e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PIK3CD—breast cancer	3.48e-06	2.13e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—NRG1—breast cancer	3.48e-06	2.13e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—H2AFX—breast cancer	3.45e-06	2.11e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—ALB—breast cancer	3.44e-06	2.1e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PIK3CA—breast cancer	3.39e-06	2.07e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—ERCC2—breast cancer	3.33e-06	2.04e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—MTHFR—breast cancer	3.3e-06	2.02e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—NOS3—breast cancer	3.29e-06	2.01e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.28e-06	2e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—ERBB3—breast cancer	3.26e-06	1.99e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—FGFR2—breast cancer	3.25e-06	1.99e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—COMT—breast cancer	3.24e-06	1.98e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GSTP1—breast cancer	3.23e-06	1.97e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—HMOX1—breast cancer	3.18e-06	1.95e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ITPR1—breast cancer	3.18e-06	1.94e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—MTHFR—breast cancer	3.13e-06	1.91e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—TERT—breast cancer	3.12e-06	1.91e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ABCB1—breast cancer	3.06e-06	1.87e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CAV1—breast cancer	3.05e-06	1.86e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PIK3CB—breast cancer	3.04e-06	1.86e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—FGFR1—breast cancer	3.03e-06	1.85e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PTGS2—breast cancer	3.01e-06	1.84e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—TYMS—breast cancer	3e-06	1.84e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—HIF1A—breast cancer	2.99e-06	1.83e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PLA2G4A—breast cancer	2.97e-06	1.81e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GSTM1—breast cancer	2.97e-06	1.81e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—NCOR1—breast cancer	2.97e-06	1.81e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.91e-06	1.78e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CAV1—breast cancer	2.89e-06	1.77e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—MAPK3—breast cancer	2.88e-06	1.76e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GPX1—breast cancer	2.84e-06	1.74e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CYP1A1—breast cancer	2.81e-06	1.72e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—MYC—breast cancer	2.8e-06	1.71e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ERCC2—breast cancer	2.79e-06	1.71e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PIK3CG—breast cancer	2.78e-06	1.7e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—AKT1—breast cancer	2.77e-06	1.69e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—NOS2—breast cancer	2.72e-06	1.66e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—NOTCH1—breast cancer	2.69e-06	1.64e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—KIT—breast cancer	2.63e-06	1.61e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—APC—breast cancer	2.63e-06	1.61e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PTEN—breast cancer	2.62e-06	1.6e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—MTHFR—breast cancer	2.62e-06	1.6e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—EGF—breast cancer	2.6e-06	1.59e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—BRAF—breast cancer	2.47e-06	1.51e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PIK3CD—breast cancer	2.44e-06	1.49e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CAV1—breast cancer	2.42e-06	1.48e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ALB—breast cancer	2.41e-06	1.47e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—AKT2—breast cancer	2.41e-06	1.47e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—PIK3CD—breast cancer	2.31e-06	1.41e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.31e-06	1.41e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—NOS3—breast cancer	2.3e-06	1.41e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—SERPINE1—breast cancer	2.29e-06	1.4e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PIK3CG—breast cancer	2.2e-06	1.35e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—NOS3—breast cancer	2.18e-06	1.34e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PIK3CB—breast cancer	2.13e-06	1.3e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PTGS2—breast cancer	2.11e-06	1.29e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—MDM2—breast cancer	2.07e-06	1.27e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—RAF1—breast cancer	2.06e-06	1.26e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—ERBB2—breast cancer	2.04e-06	1.25e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—MTOR—breast cancer	2.02e-06	1.23e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—PIK3CB—breast cancer	2.02e-06	1.23e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CD4—breast cancer	2.01e-06	1.23e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—AKT1—breast cancer	1.94e-06	1.19e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PIK3CD—breast cancer	1.94e-06	1.18e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ALB—breast cancer	1.91e-06	1.17e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CDKN1B—breast cancer	1.89e-06	1.16e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PIK3CA—breast cancer	1.85e-06	1.13e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PTEN—breast cancer	1.84e-06	1.12e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—NOS3—breast cancer	1.83e-06	1.12e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CTNNB1—breast cancer	1.79e-06	1.09e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CDKN1A—breast cancer	1.75e-06	1.07e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—PTEN—breast cancer	1.74e-06	1.07e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PIK3CB—breast cancer	1.69e-06	1.03e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—SRC—breast cancer	1.62e-06	9.88e-06	CbGpPWpGaD
Icosapent—PTGS2—Disease—STAT3—breast cancer	1.56e-06	9.53e-06	CbGpPWpGaD
Icosapent—PPARG—Metabolism—AKT1—breast cancer	1.51e-06	9.24e-06	CbGpPWpGaD
Icosapent—PTGS2—Disease—MAPK3—breast cancer	1.49e-06	9.1e-06	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PTEN—breast cancer	1.46e-06	8.92e-06	CbGpPWpGaD
Icosapent—PTGS2—Disease—MYC—breast cancer	1.45e-06	8.85e-06	CbGpPWpGaD
Icosapent—PTGS2—Disease—TGFB1—breast cancer	1.44e-06	8.83e-06	CbGpPWpGaD
Icosapent—PTGS2—Disease—EGFR—breast cancer	1.42e-06	8.66e-06	CbGpPWpGaD
Icosapent—PTGS2—Disease—KRAS—breast cancer	1.34e-06	8.18e-06	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PIK3CA—breast cancer	1.3e-06	7.93e-06	CbGpPWpGaD
Icosapent—PTGS2—Disease—PIK3CA—breast cancer	1.23e-06	7.51e-06	CbGpPWpGaD
Icosapent—PTGS2—Disease—HRAS—breast cancer	1.14e-06	6.95e-06	CbGpPWpGaD
Icosapent—PTGS2—Disease—IL6—breast cancer	1.09e-06	6.65e-06	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—AKT1—breast cancer	1.06e-06	6.48e-06	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PIK3CA—breast cancer	1.03e-06	6.29e-06	CbGpPWpGaD
Icosapent—PTGS2—Disease—AKT1—breast cancer	1e-06	6.14e-06	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—AKT1—breast cancer	8.41e-07	5.14e-06	CbGpPWpGaD
